the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences
Japanese Chinese

Market Research Report

Partnering with Bigpharma: The definitive guide to partnering interests, contacts & agreements

Published by CurrentPartnering, a division of Wildwood Ventures Limited Contact us : +1-860-674-8796
Published 2008/07 Content info 647 pages
Product code WILD70592
Price From  US $ 2995 Order/Price list
US $ 2995 CD-ROM (Single User License)
US $ 2995 PDF by E-mail (Single User License)
US $ 3345 Hard Copy (Single User License)
US $ 8995 CD-ROM (Site License)
US $ 8995 PDF by E-mail (Site License)
US $ 9345 Hard Copy (Site License)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Bigpharma - The Top 50

Chapter 3 - Most active bigpharma dealmakers

  • 3.1 Bigpharma M&A activity
  • 3.2 Bigpharma partnering

Chapter 4 - Top bigpharma deals - 2000-7

  • 4.1 Bigpharma M&A
  • 4.2 Bigpharma partnering

Chapter 5 - Submitting Opportunities to Bigpharma

  • 5.1 How to submit an opportunity
  • 5.2 Opportunity submission template
  • 5.3 Sending emails
  • 5.4 Face to face at partnering events
  • 5.5 Online submission forms

Chapter 6 - Forthcoming bigpharma partnering events

  • 6.1 Forthcoming events

Chapter 7 - Bigpharma company - therapy locator

  • 7.1 How to use the therapy matrix tables
  • 7.2 Therapeutic area definitions
  • 7.3 Bigpharma - Therapeutic target matrix - marketed and pipeline compounds
  • 7.5 Bigpharma - Therapeutic target matrix - expressed partnering interests
  • 7.6 Bigpharma - Therapeutic target matrix - recent deals - 2005-2007

Chapter 8 - Bigpharma Company Profiles

  • 8.1 How to use company profiles
  • 8.2 Field definitions
  • 8.3 Company profiles
    • Abbott
    • Actavis
    • Allergan
    • Amgen
    • Astellas
    • AstraZeneca
    • Barr Pharmaceuticals
    • Baxter International
    • Bayer
    • Biogen Idec
    • Biogen Idec
    • Boehringer Ingelheim
    • Bristol-Myers Squibb
    • Chugai
    • CSL
    • Daiichi Sankyo
    • Eisai
    • Eli Lilly
    • Forest Laboratories
    • Genentech
    • Genzyme
    • Gilead Sciences
    • GlaxoSmithKline
    • Johnson & Johnson
    • King
    • Lundbeck
    • Menarini
    • Merck & Co
    • Merck Serono KGaA
    • Mitsubishi-Tanabe
    • Mundipharma
    • Novartis AG
    • Novo Nordisk
    • Nycomed Pharma
    • Otsuka
    • Pfizer
    • Procter & Gamble
    • Ratiopharm
    • Roche
    • Sanofi-Aventis
    • Schering Plough
    • Servier
    • Shire
    • Solvay
    • Stada
    • Takeda
    • Teva
    • UCB
    • Watson
    • Wyeth

About Current@Partnering

Recent report titles from Current@Partnering

Order Form - Reports

Order Form - Report Update Subscription

Order form - Company Dealmaking Profiles

Order Form - CD-Rom

Figures in report

  • Figure 1: Bigpharma - top 50 by pharma revenues 2007
  • Figure 2: Leading Bigpharma M&A companies, 2005-7
  • Figure 3: Leading Bigpharma partnering companies, 2005-7
  • Figure 4: Leading M&A deals involving bigpharma by value, 2005-7
  • Figure 5: Leading partnering deals by value, 2005-7
  • Figure 6: Typical partnering opportunity submission template
  • Figure 7: Partnering events 2008-9
  • Figure 8: Therapeutic area definitions
  • Figure 9: Therapeutic target matrix - marketed and pipeline compounds
  • Figure 10: Therapeutic target matrix - expressed partnering interests
  • Figure 11: Therapeutic target matrix - recent deals 2005-7
  • Figure 12: Company profile template and definitions used in report
  • Figure 13: Abbott - Dealmaking frequency 2000-2007
  • Figure 14: Abbott - recent deals (2005-2008) by deal type
  • Figure 15: Abbott - recent deals (2005 - 2008) by stage of development
  • Figure 16: Abbott - recent deals (2005 - 2008) by therapy area
  • Figure 17: Recent Abbott partnering deals (2003-2008) where contract document available
  • Figure 18: Actavis - Dealmaking frequency 2000-2007
  • Figure 19: Actavis - recent deals (2005-2008) by deal type
  • Figure 20: Actavis - recent deals (2005 - 2008) by stage of development
  • Figure 21: Actavis - recent deals (2005 - 2008) by therapy area
  • Figure 22: Recent Actavis partnering deals (2003-2008) where contract document available
  • Figure 23: Alcon Labs dealmaking frequency 2000-2007
  • Figure 24: Alcon Labs - recent deals (2005 - 2008) by deal type
  • Figure 25: Alcon Labs - recent deals (2005 - 2008) by stage of development
  • Figure 26: Alcon Labs - recent deals (2005 - 2008) by therapy area
  • Figure 27: Recent Alcon Labs partnering deals (2003-2008) where contract document available
  • Figure 28: Allergan - Dealmaking frequency 2000-2007
  • Figure 29: Allergan - recent deals (2005-2008) by deal type
  • Figure 30: Allergan - recent deals (2005 - 2008) by stage of development
  • Figure 31: Allergan - recent deals (2005 - 2008) by therapy area
  • Figure 32: Recent Allergan partnering deals (2003-2008) where contract document available
  • Figure 33: Amgen - Dealmaking frequency 2000-2007
  • Figure 34: Amgen - recent deals (2005-2008) by deal type
  • Figure 35: Amgen - recent deals (2005 - 2008) by stage of development
  • Figure 36: Amgen - recent deals (2005 - 2008) by therapy area
  • Figure 37: Recent Amgen partnering deals (2003-2008) where contract document available
  • Figure 38: Astellas - Dealmaking frequency 2000-2007
  • Figure 39: Astellas - recent deals (2005-2008) by deal type
  • Figure 40: Astellas - recent deals (2005 - 2008) by stage of development
  • Figure 41: Astellas - recent deals (2005 - 2008) by therapy area
  • Figure 42: Recent Astellas partnering deals (2003-2008) where contract document available
  • Figure 43: AstraZeneca - Dealmaking frequency 2000-2007
  • Figure 44: AstraZeneca - recent deals (2005-2008) by deal type
  • Figure 45: AstraZeneca - recent deals (2005 - 2008) by stage of development
  • Figure 46: AstraZeneca - recent deals (2005 - 2008) by therapy area
  • Figure 47: Recent AstraZeneca partnering deals (2003-2008) where contract document available
  • Figure 208: Barr - Dealmaking frequency 2000-2007
  • Figure 219: Barr - recent deals (2005-2008) by deal type
  • Figure 220: Barr - recent deals (2005 - 2008) by stage of development
  • Figure 221: Barr - recent deals (2005 - 2008) by therapy area
  • Figure 222: Recent Barr partnering deals (2003-2008) where contract document available
  • Figure 48: Baxter - Dealmaking frequency 2000-2007
  • Figure 49: Baxter - recent deals (2005-2008) by deal type
  • Figure 50: Baxter - recent deals (2005 - 2008) by stage of development
  • Figure 51: Baxter - recent deals (2005 - 2008) by therapy area
  • Figure 52: Recent Baxter partnering deals (2003-2008) where contract document available
  • Figure 53: Bayer - Dealmaking frequency 2000-2007
  • Figure 54: Bayer - recent deals (2005-2008) by deal type
  • Figure 55: Bayer - recent deals (2005 - 2008) by stage of development
  • Figure 56: Bayer - recent deals (2005 - 2008) by therapy area
  • Figure 57: Recent Bayer partnering deals (2003-2008) where contract document available
  • Figure 58: Biogen Idec - Dealmaking frequency 2000-2007
  • Figure 59: Biogen Idec - recent deals (2005 - 2008) by deal type
  • Figure 60: Biogen Idec - recent deals (2005 - 2008) by stage of development
  • Figure 61: Biogen Idec - recent deals (2005 - 2008) by therapy area
  • Figure 62: Recent Biogen Idec partnering deals (2003-2008) where contract document available
  • Figure 63: Boehringer Ingelheim - Dealmaking frequency 2000-2007
  • Figure 64: Boehringer Ingelheim - recent deals (2005 - 2008) by deal type
  • Figure 65: Boehringer Ingelheim - recent deals (2005 - 2008) by stage of development
  • Figure 66: Boehringer Ingelheim - recent deals (2005 - 2008) by therapy area
  • Figure 67: Recent Boehringer Ingelheim partnering deals (2003-2008) where contract document available
  • Figure 68: Bristol-Myers Squibb - Dealmaking frequency 2000-2007
  • Figure 69: Bristol-Myers Squibb - recent deals (2005 - 2008) by deal type
  • Figure 70: Bristol-Myers Squibb - recent deals (2005 - 2008) by stage of development
  • Figure 71: Bristol-Myers Squibb - recent deals (2005 - 2008) by therapy area
  • Figure 72: Recent Bristol-Myers Squibb partnering deals (2003-2008) where contract document available
  • Figure 73: Chugai - Dealmaking frequency 2000-2007
  • Figure 74: Chugai - recent deals (2005-2008) by deal type
  • Figure 75: Chugai - recent deals (2005 - 2008) by stage of development
  • Figure 76: Chugai - recent deals (2005 - 2008) by therapy area
  • Figure 77: Recent Chugai partnering deals (2003-2008) where contract document available
  • Figure 78: CSL - Dealmaking frequency 2000-2007
  • Figure 79: CSL - recent deals (2005-2008) by deal type
  • Figure 80: CSL - recent deals (2005 - 2008) by stage of development
  • Figure 81: CSL - recent deals (2005 - 2008) by therapy area
  • Figure 82: Recent CSL partnering deals (2003-2008) where contract document available
  • Figure 208: DaiichiSankyo - Dealmaking frequency 2000-2007
  • Figure 219: DaiichiSankyo - recent deals (2005-2008) by deal type
  • Figure 220: DaiichiSankyo - recent deals (2005 - 2008) by stage of development
  • Figure 221: DaiichiSankyo - recent deals (2005 - 2008) by therapy area
  • Figure 222: Recent DaiichSankyo partnering deals (2003-2008) where contract document available
  • Figure 83: Eisai - Dealmaking frequency 2000-2007
  • Figure 84: Eisai - recent deals (2005-2008) by deal type
  • Figure 85: Eisai - recent deals (2005 - 2008) by stage of development
  • Figure 86: Eisai - recent deals (2005 - 2008) by therapy area
  • Figure 87: Recent Eisai partnering deals (2003-2008) where contract document available
  • Figure 88: Eli Lilly - Dealmaking frequency 2000-2007
  • Figure 89: Eli Lilly - recent deals (2005-2008) by deal type
  • Figure 90: Eli Lilly - recent deals (2005 - 2008) by stage of development
  • Figure 91: Eli Lilly - recent deals (2005 - 2008) by therapy area
  • Figure 92: Recent Eli Lilly partnering deals (2003-2008) where contract document available
  • Figure 93: Forest - Dealmaking frequency 2000-2007
  • Figure 94: Forest - recent deals (2005-2008) by deal type
  • Figure 95: Forest - recent deals (2005 - 2008) by stage of development
  • Figure 96: Forest - recent deals (2005 - 2008) by therapy area
  • Figure 97: Recent Forest partnering deals (2003-2008) where contract document available
  • Figure 98: Genentech - Dealmaking frequency 2000-2007
  • Figure 99: Genentech - recent deals (2005-2008) by deal type
  • Figure 100: Genentech - recent deals (2005 - 2008) by stage of development
  • Figure 101: Genentech - recent deals (2005 - 2008) by therapy area
  • Figure 102: Recent Genentech partnering deals (2003-2008) where contract document available
  • Figure 103: Genzyme - Dealmaking frequency 2000-2007
  • Figure 104: Genzyme - recent deals (2005-2008) by deal type
  • Figure 105: Genzyme - recent deals (2005 - 2008) by stage of development
  • Figure 106: Genzyme - recent deals (2005 - 2008) by therapy area
  • Figure 107: Recent Genzyme partnering deals (2003-2008) where contract document available
  • Figure 108: Gilead - Dealmaking frequency 2000-2007
  • Figure 109: Gilead - recent deals (2005-2008) by deal type
  • Figure 110: Gilead - recent deals (2005 - 2008) by stage of development
  • Figure 111: Gilead - recent deals (2005 - 2008) by therapy area
  • Figure 112: Recent Gilead partnering deals (2003-2008) where contract document available
  • Figure 113: GlaxoSmithKline - Dealmaking frequency 2000-2007
  • Figure 114: GlaxoSmithKline - recent deals (2005-2008) by deal type
  • Figure 115: GlaxoSmithKline - recent deals (2005 - 2008) by stage of development
  • Figure 116: GlaxoSmithKline - recent deals (2005 - 2008) by therapy area
  • Figure 117: Recent GlaxoSmithKline partnering deals (2003-2008) where contract document available
  • Figure 118: Johnson & Johnson - Dealmaking frequency 2000-2007
  • Figure 119: Johnson & Johnson - recent deals (2005-2008) by deal type
  • Figure 120: Johnson & Johnson - recent deals (2005 - 2008) by stage of development
  • Figure 121: Johnson & Johnson - recent deals (2005 - 2008) by therapy area
  • Figure 122: Recent Johnson & Johnson partnering deals (2003-2008) where contract document available
  • Figure 123: King Pharmaceuticals - Dealmaking frequency 2000-2007
  • Figure 124: King - recent deals (2005-2008) by deal type
  • Figure 125: King - recent deals (2005 - 2008) by stage of development
  • Figure 126: King - recent deals (2005 - 2008) by therapy area
  • Figure 127: Recent King partnering deals (2003-2008) where contract document available
  • Figure 128: Lundbeck - Dealmaking frequency 2000-2007
  • Figure 129: Lundbeck - recent deals (2005-2008) by deal type
  • Figure 130: Lundbeck - recent deals (2005 - 2008) by stage of development
  • Figure 131: Lundbeck - recent deals (2005 - 2008) by therapy area
  • Figure 132: Recent Lundbeck partnering deals (2003-2008) where contract document available
  • Figure 133: Menarini - Dealmaking frequency 2000-2007
  • Figure 134: Menarini - recent deals (2005-2008) by deal type
  • Figure 135: Menarini - recent deals (2005 - 2008) by stage of development
  • Figure 136: Menarini - recent deals (2005 - 2008) by therapy area
  • Figure 137: Recent Menarini partnering deals (2003-2008) where contract document available
  • Figure 138: Merck & Co - Dealmaking frequency 2000-2007
  • Figure 139: Merck & Co - recent deals (2005-2008) by deal type
  • Figure 140: Merck & Co - recent deals (2005 - 2008) by stage of development
  • Figure 141: Merck & Co - recent deals (2005 - 2008) by therapy area
  • Figure 142: Recent Merck & Co partnering deals (2003-2008) where contract document available
  • Figure 143: Merck KGaA - Dealmaking frequency 2000-2007
  • Figure 144: Merck KGaA - recent deals (2005-2008) by deal type
  • Figure 145: Merck KGaA - recent deals (2005 - 2008) by stage of development
  • Figure 146: Merck KGaA - recent deals (2005 - 2008) by therapy area
  • Figure 147: Recent Merck KGaA partnering deals (2003-2008) where contract document available
  • Figure 148: Mitsubishi-Tanabe - Dealmaking frequency 2000-2007
  • Figure 149: Mitsubishi-Tanabe - recent deals (2005-2008) by deal type
  • Figure 150: Mitsubishi-Tanabe - recent deals (2005 - 2008) by stage of development
  • Figure 151: Mitsubishi-Tanabe - recent deals (2005 - 2008) by therapy area
  • Figure 152: Recent Mitsubishi-Tanabe partnering deals (2003-2008) where contract document available
  • Figure 208: Mundipharma - Dealmaking frequency 2000-2007
  • Figure 219: Mundipharma - recent deals (2005-2008) by deal type
  • Figure 220: Mundipharma - recent deals (2005 - 2008) by stage of development
  • Figure 221: Mundipharma - recent deals (2005 - 2008) by therapy area
  • Figure 222: Recent Mundipharma partnering deals (2003-2008) where contract document available
  • Figure 153: Novartis - Dealmaking frequency 2000-2007
  • Figure 154: Novartis - recent deals (2005-2008) by deal type
  • Figure 155: Novartis - recent deals (2005 - 2008) by stage of development
  • Figure 156: Novartis - recent deals (2005 - 2008) by therapy area
  • Figure 157: Recent Novartis partnering deals (2003-2008) where contract document available
  • Figure 158: Novo Nordisk - Dealmaking frequency 2000-2007
  • Figure 159: Novo Nordisk - recent deals (2005-2008) by deal type
  • Figure 160: Novo Nordisk - recent deals (2005 - 2008) by stage of development
  • Figure 161: Novo Nordisk - recent deals (2005 - 2008) by therapy area
  • Figure 162: Recent Novo Nordisk partnering deals (2003-2008) where contract document available
  • Figure 163: Nycomed - Dealmaking frequency 2000-2007
  • Figure 164: Nycomed - recent deals (2005-2008) by deal type
  • Figure 165: Nycomed - recent deals (2005 - 2008) by stage of development
  • Figure 166: Nycomed - recent deals (2005 - 2008) by therapy area
  • Figure 167: Recent Nycomed partnering deals (2003-2008) where contract document available
  • Figure 168: Otsuka - Dealmaking frequency 2000-2007
  • Figure 169: Otsuka - recent deals (2005-2008) by deal type
  • Figure 170: Otsuka - recent deals (2005 - 2008) by stage of development
  • Figure 171: Otsuka - recent deals (2005 - 2008) by therapy area
  • Figure 172: Recent Otsuka partnering deals (2003-2008) where contract document available
  • Figure 173: Pfizer - Dealmaking frequency 2000-2007
  • Figure 174: Pfizer - recent deals (2005-2008) by deal type
  • Figure 175: Pfizer - recent deals (2005 - 2008) by stage of development
  • Figure 176: Pfizer - recent deals (2005 - 2008) by therapy area
  • Figure 177: Recent Pfizer partnering deals (2003-2008) where contract document available
  • Figure 178: Procter & Gamble - Dealmaking frequency 2000-2007
  • Figure 179: Procter & Gamble - recent deals (2005-2008) by deal type
  • Figure 180: Procter & Gamble - recent deals (2005 - 2008) by stage of development
  • Figure 181: Procter & Gamble - recent deals (2005 - 2008) by therapy area
  • Figure 182: Recent Procter & Gamble partnering deals (2003-2008) where contract document available
  • Figure 208: Ratiopharm - Dealmaking frequency 2000-2007
  • Figure 219: Ratiopharm - recent deals (2005-2008) by deal type
  • Figure 220: Ratiopharm - recent deals (2005 - 2008) by stage of development
  • Figure 221: Ratiopharm - recent deals (2005 - 2008) by therapy area
  • Figure 222: Recent Ratiopharm partnering deals (2003-2008) where contract document available
  • Figure 183: Roche - Dealmaking frequency 2000-2007
  • Figure 184: Roche - recent deals (2005-2008) by deal type
  • Figure 185: Roche - recent deals (2005 - 2008) by stage of development
  • Figure 186: Roche - recent deals (2005 - 2008) by therapy area
  • Figure 187: Recent Roche partnering deals (2003-2008) where contract document available
  • Figure 188: Sanofi-Aventis - Dealmaking frequency 2000-2007
  • Figure 189: Sanofi-Aventis - recent deals (2005-2008) by deal type
  • Figure 190: Sanofi-Aventis - recent deals (2005 - 2008) by stage of development
  • Figure 191: Sanofi-Aventis - recent deals (2005 - 2008) by therapy area
  • Figure 192: Recent Sanofi-Aventis partnering deals (2003-2008) where contract document available
  • Figure 193: Schering Plough - Dealmaking frequency 2000-2007
  • Figure 194: Schering Plough - recent deals (2005-2008) by deal type
  • Figure 195: Schering Plough - recent deals (2005 - 2008) by stage of development
  • Figure 196: Schering Plough - recent deals (2005 - 2008) by therapy area
  • Figure 197: Recent Schering Plough partnering deals (2003-2008) where contract document available
  • Figure 208: Servier - Dealmaking frequency 2000-2007
  • Figure 219: Servier - recent deals (2005-2008) by deal type
  • Figure 220: Servier - recent deals (2005 - 2008) by stage of development
  • Figure 221: Servier - recent deals (2005 - 2008) by therapy area
  • Figure 222: Recent Servier partnering deals (2003-2008) where contract document available
  • Figure 198: Shire - Dealmaking frequency 2000-2007
  • Figure 199: Shire - recent deals (2005-2008) by deal type
  • Figure 200: Shire - recent deals (2005 - 2008) by stage of development
  • Figure 201: Shire - recent deals (2005 - 2008) by therapy area
  • Figure 202: Recent Shire partnering deals (2003-2008) where contract document available
  • Figure 203: Solvay - Dealmaking frequency 2000-2007
  • Figure 204: Solvay - recent deals (2005-2008) by deal type
  • Figure 205: Solvay - recent deals (2005 - 2008) by stage of development
  • Figure 206: Solvay - recent deals (2005 - 2008) by therapy area
  • Figure 207: Recent Solvay partnering deals (2003-2008) where contract document available
  • Figure 208: Stada - Dealmaking frequency 2000-2007
  • Figure 219: Stada - recent deals (2005-2008) by deal type
  • Figure 220: Stada - recent deals (2005 - 2008) by stage of development
  • Figure 221: Stada - recent deals (2005 - 2008) by therapy area
  • Figure 222: Recent Stada partnering deals (2003-2008) where contract document available
  • Figure 208: Takeda - Dealmaking frequency 2000-2007
  • Figure 209: Takeda - recent deals (2005-2008) by deal type
  • Figure 210: Takeda - recent deals (2005 - 2008) by stage of development
  • Figure 211: Takeda - recent deals (2005 - 2008) by therapy area
  • Figure 212: Recent Takeda partnering deals (2003-2008) where contract document available
  • Figure 208: Teva - Dealmaking frequency 2000-2007
  • Figure 219: Teva - recent deals (2005-2008) by deal type
  • Figure 220: Teva - recent deals (2005 - 2008) by stage of development
  • Figure 221: Teva - recent deals (2005 - 2008) by therapy area
  • Figure 222: Recent Teva partnering deals (2003-2008) where contract document available
  • Figure 213: UCB Group - Dealmaking frequency 2000-2007
  • Figure 214: UCB Group - recent deals (2005-2008) by deal type
  • Figure 215: UCB Group - recent deals (2005 - 2008) by stage of development
  • Figure 216: UCB Group - recent deals (2005 - 2008) by therapy area
  • Figure 217: Recent UCB Group partnering deals (2003-2008) where contract document available
  • Figure 218: Watson - Dealmaking frequency 2000-2007
  • Figure 219: Watson - recent deals (2005-2008) by deal type
  • Figure 220: Watson - recent deals (2005 - 2008) by stage of development
  • Figure 221: Watson - recent deals (2005 - 2008) by therapy area
  • Figure 222: Recent Watson partnering deals (2003-2008) where contract document available
  • Figure 223: Wyeth - Dealmaking frequency 2000-2007
  • Figure 224: Wyeth - recent deals (2005-2008) by deal type
  • Figure 225: Wyeth - recent deals (2005 - 2008) by stage of development
  • Figure 226: Wyeth - recent deals (2005 - 2008) by therapy area
  • Figure 227: Recent Wyeth partnering deals (2003-2008) where contract document available
  • Figure 228: Online partnering resources
  • Figure 229: Development and license agreement between Boehringer Ingelheim and Inspire Pharmaceuticals, February 2006
Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.